Parexel International Corp., a research organization that does subcontracting work for biotech companies, plans to cut between 1,100 and 1,200 jobs worldwide in an expansion of a restructuring plan the Waltham-based business announced in January.
In a May 4 regulatory filing, Parexel didn’t specify how many of the anticipated job cuts will be in its home state of Massachusetts where it employs more than 1,000 workers.
Early this year, Parexel said it expected to eliminate about 400 jobs in a “rightsizing” push to save costs and boost productivity. Parexel executives have been talking to investment bankers about selling the company, according to a report in the Wall Street Journal.Robert Weisman can be reached at firstname.lastname@example.org. Follow him on Twitter @GlobeRobW.